Trial intelligence / Profile preview

Herbal and animal ointment for diabetic foot ulcers

IRCT20230111057111N1Phase 2Completed

Sponsor
Islamic Azad University
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of shikonin in diabetic foot ulcer (DFU) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Local infection, Wound degree and size and 3 more. Started Jan 2023; status: completed.

02

Drugs

shikonin
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on IRCT20230111057111N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230111057111N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call